Severe Hypoglycemia Risk Factors Identified in Insulin-Treated Type 2 Diabetes
Investigators sought to identify factors associated with increased risk for severe hypoglycemia among patients with insulin-treated type 2 diabetes.
Investigators sought to identify factors associated with increased risk for severe hypoglycemia among patients with insulin-treated type 2 diabetes.
Nonalcoholic fatty liver disease is associated with a higher risk for severe hypoglycemia in patients with type 2 diabetes.
Type 1 and type 2 diabetes in children, adolescents, and young adults showed poor glycemic control in earlier studies. A new study looked for signs of improvement.
Continuous subcutaneous insulin infusion revolutionized insulin delivery for people with type 1 diabetes. Researchers measured several devices and their effects on glycated hemoglobin levels, in addition to telehealth support, over a 3 month period.
This retrospective study aimed to determine the incidence of treatment deintensification in a real-world setting.
Type 1 diabetes occurs at any age and can be misdiagnosed as type 2 diabetes in adults. Better testing methods and professional education are needed.
For older adults with diabetes hospitalized for common medical conditions, discharge with intensified diabetes medications increases short-term risk for severe hypoglycemia but does not reduce severe hyperglycemia events or HbA1c levels within one year.
People with type 1 diabetes often have trouble achieving strict glycemic control, even with new insulin analogs and glucose monitoring systems. Researchers investigated whether efficacy could be improved with adjunct therapy.
The use of affected product may fail to treat patients with severe hypoglycemia due to a loss of potency.
An experimental, injectable drug for type 2 diabetes may be superior to insulin for both glycemic and weight control.